DMC Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
DMC Group's NVO Position: Q1 2026 in Review
DMC Group reduced its Novo Nordisk (NVO) stake by 6.7% in Q1 2026, selling an estimated $33.4K and leaving 9,754 shares worth $358K. The position accounts for 0.24% of the portfolio, ranked #103.
DMC Group first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- DMC Group held 9,754 shares of Novo Nordisk worth $358K as of Q1 2026.
- DMC Group sold 704 Novo Nordisk shares in Q1 2026, an estimated $33.4K.
- Novo Nordisk made up 0.24% of DMC Group's portfolio in Q1 2026, its #103 holding.
- DMC Group first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
- DMC Group's Novo Nordisk position peaked at $1.79M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.